Zymtronix Is A Biotechnology Company Based In Durhamnorth Carolinaspecializing In Advanced Cell Free Systems For Industrial Biotechnologyfounded In 2013The Company Integrates Multi Scale Platform Technologies To Enhance The Use Of Enzymescontributing To Advancements In Green Chemistry And Biocatalysis The Primary Service Offered By Zymtronix Involves The Development And Application Of Cell Freemulti Enzyme Systems Aimed At Producing High Value Industrial Productstheir Technology Focuses On Enzyme Immobilization And Multi Enzyme Processeswhich Improve Substrate Conversionslower Production Costsand Reduce Environmental Impactzymtronix Targets Industries Such As Agriculturenutritioncosmeticsand Pharmaceuticalsproviding Solutions That Benefit From Biocatalytic Processes Zymtronix Has Filed 12 Patentsshowcasing Its Commitment To Innovation In Biotechnologythe Company Has Raised Approximately $3 61 Million In Funding And Is Currently Active In Its Growth Stageunder The Leadership Of Ceo Stephane Corgiezymtronix Continues To Position Itself As A Leader In Sustainable Biomanufacturing Practices
